Skip to main content
. Author manuscript; available in PMC: 2018 Mar 28.
Published in final edited form as: Cancer Lett. 2016 Dec 23;389:33–40. doi: 10.1016/j.canlet.2016.12.020

Fig 3.

Fig 3

Cisplatin resistant HNSCC cells are sensitive to BAY and YC-1. UM1-CisR and CAL27-CisR cells and their parental lines were treated with increasing doses of cisplatin (A), YC-1 (B) or BAY (C) for 72h. Cell viability was determined by MTT assay. Each value is a mean±SEM of 6 replicates.